{
    "id": "5c6b7bee7c78d6947100002a",
    "question": "Is dupilumab effective for treatment of asthma?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"Dupilumab is a biologic medication that targets interleukin-4 receptor alpha (IL-4R\\u00ce alpha) and interleukin-13 (IL-13), which are key players in the inflammatory process of asthma. Asthma is a chronic inflammatory disease of the airways characterized by recurring episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or early in the morning. Dupilumab has been shown to reduce inflammation and improve lung function in patients with moderate-to-severe asthma who have not responded to other treatments. It has been approved by regulatory agencies for the treatment of asthma in adults and children aged 6 years and older. The medication has been shown to reduce symptoms, improve lung function, and decrease the frequency of exacerbations in clinical trials. Therefore, dupilumab is considered an effective treatment option for patients with asthma who have not responded to other therapies.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 41.012146949768066
}